Tekmira Pharmaceuticals’ chief executive this week confirmed that the company will begin a second phase I study in its hypercholesterolemia program with a second-generation drug candidate in the second half of 2010, while providing a few new details about the problems experienced with the initial therapeutic agent.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2’s funding will enable new research investigating IDH1 gene mutations in brain cancer …
Article by Terry Johnston.
Cleaning drinking water is important! And there are 4 reasons you need to do it. Chlorine, Aspartame, pharmaceuticals, and hormones. These are chemicals that are still in your drinking water, when it arrives at your home.
BELLUS Health Inc. and its subsidiaries, formerly known as Neurochem Inc. (BELLUS Health) is a global health company focused on the development and commercialization of products to provide health solutions to address critical unmet needs.
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, 2-hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas, the …
